There are 200 million people worldwide with cardiac symptoms. The severity and frequency of these symptoms are not always indicative of the potential associated risk. However, swift action is needed if critical cardiac events occur. Individuals are often on their own to decide what may be a serious event and what to do about it. Capturing a symptomatic event when it occurs and providing individuals with a profound medical trigger to act when a serious event strikes lie at the heart of our enterprise. The founders created Personal MedSystems in 2008 to bring their idea of a small, smartphone-based, but uniquely profound, ECG device with a trigger to act to life: CardioSecur.

There are 200 million people worldwide with cardiac symptoms. The severity and frequency of these symptoms are not always indicative of the potential associated risk. However, swift action is needed if critical cardiac events occur. Individuals are often on their own to decide what may be a serious event and what to do about it. Capturing a symptomatic event when it occurs and providing individuals with a profound medical trigger to act when a serious event strikes lie at the heart of our enterprise. The founders created Personal MedSystems in 2008 to bring their idea of a small, smartphone-based, but uniquely profound, ECG device with a trigger to act to life: CardioSecur.

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.